88IV - PR Newswire Asia's news - Health Care/Hospital


SynuSight-Shanghai Jiao Tong University Collaboration Published in Cell, Advancing Diagnostic Classification of Synucleinopathies SHANGHAI , May 27, 2026 /PRNewswire/ -- SynuSight Biotech (SynuSight), a clinical-stage biotech company focused on innovative pipeline development for neurodegenerative diseases, today announced the ... 2026-05-27T Biotechnology Health Care/Hospital Publishing/Information Service
From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery SHANGHAI , May 27, 2026 /PRNewswire/ -- On May 20, 2026, Viva Biotech hosted a V-Experts in Conversation webinar, " Managing Complexity in Modern Drug Discovery: A Practical Approach to Integrated ... 2026-05-27T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Sisram Medical Investor Day Key Takeaways Advancing Global Medical Aesthetics Strategy and Unl ock ing Wellness Platform Value ... 2026-05-27T Banking/Financial Service Cosmetics & Personal Care Health Care/Hospital Household/Consumer/Cosmetics
From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery SHANGHAI , May 27, 2026 /PRNewswire/ -- On May 20, 2026, Viva Biotech hosted a V-Experts in Conversation webinar, "Managing Complexity in Modern Drug Discovery: A Practical Approach to Integrated ... 2026-05-27T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Brii Bio Presents Late-Breaking Data from Its Phase 2 ENSURE Study at EASL Congress 2026, Further Supporting the Potential Role of BRII-179 in Achieving Durable Immunological Control of HBV - Final results from the ENSURE study demonstrate that the addition of elebsiran resulted in a higher functional cure rate compared with pegylated interferon alfa (PEG-IFNα) alone ... 2026-05-27T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Dizal's ZEGFROVY® (Sunvozertinib) New Drug Application Accepted and Granted Priority Review by China National Medical Products Administration for First-Line Treatment of EGFR Exon 20 Insertion-Mutated Non-Small Cell Lung Cancer SHANGHAI , May 27, 2026 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of oncology and hematological diseases, announced that ... 2026-05-27T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Fosun International Recognized on Fortune's 2026 "Most Admired Chinese Companies" List HONG KONG , May 27, 2026 /PRNewswire/ -- On 27 May 2026, Fortune China magazine released its 2026 list of "Most Admired Chinese Companies", in which Fosun International Limited ("Fosun ... 2026-05-27T Health Care/Hospital Medical/Pharmaceuticals
Announcement of The Shaw Laureates 2026 HONG KONG , May 27, 2026 /PRNewswire/ -- The Shaw Prize in Astronomy is awarded in equal shares to ... 2026-05-27T Biotechnology Computer/Electronics Education Health Care/Hospital
WuXi Biologics Achieves GMP Release of 18th Drug Product Facility, Advancing Integrated Drug Substance to Drug Product Capabilities SHANGHAI , May 27, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that its Drug Product Facility 15 (DP15), ... 2026-05-27T Banking/Financial Service Biotechnology Health Care/Hospital Medical/Pharmaceuticals
CGBIO Signs Global Clinical and Exclusive Commercialization Agreement for NOVOSIS in the U.S., Canada and Australia DePuy Synthes secures exclusive commercialization rights in North America and Australia; the two companies to jointly advance global clinical development and regulatory approvals, including FDA IDE and ... 2026-05-27T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals

PR Newswire Asia's news > Health Care/Hospital